维普期刊资源整合服务平台（V6.5）

294篇 您的检索式：作者名="DIXON JM"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Periductal Mastitis/Duct Ectasia显示文摘	Dixon JM	1989	World J Surg1989，13，6：	1
2	Colour doppoler ultrasonography studies of benign and malignant breast lesions显示文摘	Dixon JM Walsh J Paterson D	1992	Br J Surg1992，79，3：	1
3	The prevention,detection,and management of breast cancer显示文摘	Houssami N Cuzick J Dixon JM	2006	Med J Aust2006，184，：	1
4	Pefiductal mastitis and duct ectasia:different conditions with different aetiologies显示文摘	Ravisekar O Chetty U	1996	Br J Surg1996，83，：	1
5	Neoadjuvant endocrine therapy of breast cancer : a surgical perspective 显示文摘	Dixon JM Anderson TJ Miller WR	2002	Eur J Cancer2002，38，17：	1
6	Are the lesions of the duct ectasia sterile?显示文摘	Bundred NJ Dixon JM Lumsden AB	1985	Br J Surg1985，72，：	1
7	Invasive cribriform carcinoma of the breast显示文摘	Page DL Dixon JM Anderson TJ	1983	Histopathology1983，7，：	1
8	Letrozle as primary medical therapy for locally advanced and large operable breast cancer显示文摘	Dixon JM Love CD	2001	Breast Cancer Res Treat2001，66，3：	1
9	Periduetal mastitis/duet ectasia显示文摘	Dixon JM	1989	World J Surg1989，13，6：	1
10	Detection of Cyclospora cayetanensis oocysts in human fecal specimens by flow cytometry显示文摘	Dixon BR Mussey JM Parrington LT	2005	J Clin Microbiol2005，43，5：	1
11	Thickened endometrium caused by tamoxifen returns to normal following tamoxifen cessation显示文摘	Love CD Dixon JM	2000	Breast2000，9，3：	1
12	Breastcancer-epi-demiology* risk factors and genetics 显示文摘	McPherson K Steel CM Dixon JM	2000	BMJ2000，321，7261：	1
13	Local endocrine effects of aromatase inhibitors within the berast 显示文摘	Miller WR Dixon JM	2001	J Steroid Biochem Mol Biol2001，79，15：	1
14	Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis 显示文摘	Araujo AB Dixon JM Suarez EA	2011	J Clin Endocrinol Metab2011，96，10：	1
15	Biomarker changes during neoadjuvant anastrozole,tamoxifen,or the combination:influence of hormonal status and HER-2 in breast cancer-a study from the IMPACT trialists显示文摘	Dowsett M Ebbs SR Dixon JM	2005	J Clin Oncol2005，23，11：	1
16	Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination : influence of hormonal status and HER-2 in breast cancer a study from the IMPACT trialists 显示文摘	Dowsett M Ebbs SR Dixon JM	2005	ClinOnco12005，23，11：	1
17	Neoadjuvant endocrine therapy of breast cancer:a surgical perspective显示文摘	Dixon JM Anderson TJ Miller WR		0，，：	1
18	Letrozole as primary medical therapy for locally advanced and large operable breast cancer 显示文摘	Dixon JM Love CD Bellamy CO	2001	Breast Cancer Res Treat2001，66，3：	1
19	Factors affecting morbidity and mortality after surgery for obstructive jaundice:a review of 373patients显示文摘	Dixon JM Armstrong CP Dutty SW	1983	Gut1983，24，9：	1
20	Endocrine and clinical endpoints of exemestane as neoadjuvant therapy显示文摘	Miller WR Dixon JM	2002	Cancer Control2002，9，2：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示